Xuesi Wan

643 total citations
23 papers, 438 citations indexed

About

Xuesi Wan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Xuesi Wan has authored 23 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Xuesi Wan's work include Diabetes Management and Research (8 papers), Diabetes Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Xuesi Wan is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Xuesi Wan collaborates with scholars based in China, United States and Australia. Xuesi Wan's co-authors include Yanbing Li, Zhimin Huang, Haipeng Xiao, Lijuan Xu, Liehua Liu, Weijian Ke, Juan Liu, Xiaopei Cao, Xiaoying He and Ailing Chen and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Xuesi Wan

22 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuesi Wan China 14 174 162 120 59 54 23 438
John L. Petrie United Kingdom 10 180 1.0× 108 0.7× 143 1.2× 51 0.9× 67 1.2× 10 366
Jinming Yao China 13 137 0.8× 156 1.0× 48 0.4× 55 0.9× 38 0.7× 34 392
Elvira Angotti Italy 10 94 0.5× 97 0.6× 69 0.6× 32 0.5× 44 0.8× 15 310
Kai Liang China 14 132 0.8× 134 0.8× 114 0.9× 42 0.7× 120 2.2× 32 446
Ya Huang China 12 173 1.0× 77 0.5× 99 0.8× 34 0.6× 150 2.8× 23 525
Kazue Ishikawa Japan 11 127 0.7× 153 0.9× 112 0.9× 56 0.9× 32 0.6× 19 453
Longyi Zeng China 12 166 1.0× 246 1.5× 90 0.8× 23 0.4× 109 2.0× 48 445
Jingrong Lin China 12 157 0.9× 140 0.9× 163 1.4× 38 0.6× 74 1.4× 18 546
Bridgit B. Bowskill Canada 10 237 1.4× 95 0.6× 68 0.6× 44 0.7× 59 1.1× 11 457

Countries citing papers authored by Xuesi Wan

Since Specialization
Citations

This map shows the geographic impact of Xuesi Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesi Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesi Wan more than expected).

Fields of papers citing papers by Xuesi Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuesi Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesi Wan. The network helps show where Xuesi Wan may publish in the future.

Co-authorship network of co-authors of Xuesi Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuesi Wan. A scholar is included among the top collaborators of Xuesi Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuesi Wan. Xuesi Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yuqi, Wensheng Chen, Qiaohui Chen, et al.. (2025). Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease. Advanced Science. 12(37). e05168–e05168.
2.
Li, Xuhui, Xuesi Wan, Liehua Liu, et al.. (2024). Single-Cell RNA-seq Analysis Reveals a Positive Correlation between Ferroptosis and Beta-Cell Dedifferentiation in Type 2 Diabetes. Biomedicines. 12(8). 1687–1687. 1 indexed citations
3.
Liu, Liehua, Weijian Ke, Lijuan Xu, et al.. (2023). Evaluating the role of time in range as a glycemic target during short‐term intensive insulin therapy in patients with newly diagnosed type 2 diabetes. Journal of Diabetes. 15(2). 133–144. 5 indexed citations
4.
Guo, Yan, Liehua Liu, Hai Li, et al.. (2023). Steroidogenic factor 1 protects mice from obesity-induced glucose intolerance via improving glucose-stimulated insulin secretion by beta cells. iScience. 26(4). 106451–106451. 2 indexed citations
5.
Lv, Dongming, Li Zhong, Jian Tu, et al.. (2022). M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression. Oncogene. 41(12). 1727–1741. 48 indexed citations
6.
Wan, Xuesi, James A. Perry, Haichen Zhang, et al.. (2021). Heterozygosity for a Pathogenic Variant in SLC12A3 That Causes Autosomal Recessive Gitelman Syndrome Is Associated with Lower Serum Potassium. Journal of the American Society of Nephrology. 32(3). 756–765. 11 indexed citations
7.
Huang, Zhimin, Juan Liu, Xuesi Wan, et al.. (2018). Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene. Journal of Diabetes Investigation. 9(5). 1075–1083. 5 indexed citations
8.
Wan, Xuesi, Juan Liu, Zhimin Huang, Liehua Liu, & Yanbing Li. (2018). The Characteristics of Patients with Long Remission after Short-Term Insulin Intensive Therapy. Diabetes. 67(Supplement_1). 1 indexed citations
9.
10.
Xu, Lijuan, Xinwei Huang, Liehua Liu, et al.. (2017). Baseline red blood cell distribution width predicts long-term glycemic remission in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 131. 33–41. 6 indexed citations
11.
Liu, Juan, Jing Zheng, Weijian Ke, et al.. (2017). Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients. Journal of Diabetes Investigation. 9(4). 952–958. 23 indexed citations
12.
Xu, Lijuan, Pengyuan Zhang, Hongyu Guan, et al.. (2016). Vitamin D and its receptor regulate lipopolysaccharide‐induced transforming growth factor‐β, angiotensinogen expression and podocytes apoptosis through the nuclear factor‐κB pathway. Journal of Diabetes Investigation. 7(5). 680–688. 16 indexed citations
13.
Liu, Liehua, Weijian Ke, Xuesi Wan, et al.. (2015). Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission. Diabetes Research and Clinical Practice. 108(2). 250–257. 17 indexed citations
14.
Xu, Lijuan, et al.. (2013). Adverse effect of metformin therapy on serum vitamin B12 and folate: Short-term treatment causes disadvantages?. Medical Hypotheses. 81(2). 149–151. 14 indexed citations
15.
Xu, Lijuan, Xuesi Wan, Zhimin Huang, et al.. (2013). Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials. PLoS ONE. 8(4). e61387–e61387. 37 indexed citations
16.
17.
Zhu, Dingjun, Xuesi Wan, Hai Huang, et al.. (2013). Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells. Oncology Reports. 31(2). 727–736. 30 indexed citations
18.
Liu, Juan, Liehua Liu, Zhimin Huang, et al.. (2013). Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients. Endocrine Journal. 60(6). 725–732. 12 indexed citations
19.
Liu, Liehua, et al.. (2012). Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy. Diabetes Technology & Therapeutics. 14(9). 756–761. 18 indexed citations
20.
Wan, Xuesi, et al.. (2012). Fufang Xue Shuan Tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats. Experimental and Therapeutic Medicine. 4(5). 871–876. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. Petrie Breakdown of academic impact, for papers by Jinming Yao Breakdown of academic impact, for papers by Elvira Angotti Breakdown of academic impact, for papers by Kai Liang Breakdown of academic impact, for papers by Ya Huang Breakdown of academic impact, for papers by Kazue Ishikawa Breakdown of academic impact, for papers by Longyi Zeng Breakdown of academic impact, for papers by Jingrong Lin Breakdown of academic impact, for papers by Bridgit B. Bowskill
Rankless by CCL
2026